MeiraGTx

92 Britannia Walk
London
N1 7NQ
United Kingdom

Email: info@meiragtx.com

Show jobs for this employer

About MeiraGTx

MeiraGTx is committed to the development of novel gene therapies to transform the lives of patients suffering from acquired and inherited disorders.
YEAR FOUNDED:
2015
LEADERSHIP:
CEO: Alexandria Forbes
CSO: Robin Ali
CDO: Stuart Naylor
COO: Richard Giroux
CLINICAL TRIAL:
Please click here for clinical trial information.

19 articles with MeiraGTx